Opal-L

N/A

Report date: 2025/01/26 16:39:22
NME

Base Information

Drug NameOpal-L
Drug Alias NameBDM-I (Opal Biosciences)inhalant formulation of BDM-I (Opal Biosciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFungal respiratory tract infectionCystic FibrosisTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOpal Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOpal Biosciences Ltd
Inactive CompaniesN/A
Active IndicationsFungal respiratory tract infectionCystic FibrosisTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A